Retatrutide, the newest type of weight-loss drug, helped people lose an average of 70 pounds or about 30% of their body weight over 80 weeks, according to study data from the drugs manufacturer
Products marketed as BPC-157 are often sold as research chemicals and may not contain what their labels claim, raising additional concerns about their safety and quality
As of the time of writing, cagrilintide has been the subject of multiple clinical research programs and has progressed through advanced stages of clinical development
TB-500 works systemically it sequesters actin to enable cell migration, dials down NF-kB inflammatory signaling, and promotes blood vessel growth through its own VEGF pathways
At Midi, we hear from patients everyday who have questions about the best approaches for reaching a healthy weight in perimenopause and menopause